<DOC>
	<DOCNO>NCT03104517</DOCNO>
	<brief_summary>This study evaluate safety efficacy two treatment Autologous Muscle Derived Cells Urinary Sphincter Repair ( AMDC-USR ) compare placebo treatment stress urinary incontinence ( SUI ) adult female patient . Two-thirds participant receive AMDC-USR ( injection cell ) one-third receive placebo .</brief_summary>
	<brief_title>Two Treatments Autologous Muscle Derived Cells Female Urinary Sphincter Repair</brief_title>
	<detailed_description>Stress urinary incontinence ( SUI ) accidental loss urine due physical activity , laughing , cough , sneeze . Autologous Muscle Derived Cells Urinary Sphincter Repair ( AMDC-USR ) involve medical procedure participant 's muscle cell collect , process , injected tissue urinary passage . This double-blind randomized study , mean neither participant , study doctor know treatment group participant . Participants randomly choose receive injection placebo option receive injection cell completion blind portion study participation ( 12 month ) .</detailed_description>
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Incontinence , Stress</mesh_term>
	<criteria>Adult female patient primary moderatetosevere symptoms SUI least 6 month , confirm patient medical history clinical symptom , include focused incontinence evaluation . Must willing able comply study procedure , mentally competent able understand study requirement , must agree read sign informed consent form prior studyrelated procedure . Must complete least 80 % screen 3day diary . Patient symptom urge incontinence confirm basic evaluation etiology patient medical history , include focused incontinence history . Patient symptom mixed urinary incontinence urge incontinence predominant factor . Patient stress urinary incontinence symptom less 6 month prior sign inform consent . Patient previously attempt conservative treatment prior sign inform consent . ( Examples conservative treatment include behavior modification , bladder exercise , biofeedback , pelvic floor muscle therapy , etc . ) Patient BMI â‰¥ 35 . Patient routinely 2 episode awaken void normal sleeping hour . Patient maintain stable dose and/or frequency medication ( include diuretic ) know affect low urinary tract function , include limited , anticholinergic , beta 3 adrenergic receptor agonist , tricyclic antidepressant , serotoninnorepinephrine reuptake inhibitor ( SNRI ) selective serotonin reuptake inhibitor ( SSRI ) antidepressant , diuretic , alphaadrenergic blocker , least 2 week prior screen likely change course study . History cancer pelvic organ , ureter , kidney . Patient pregnant , lactate , plan become pregnant course study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Urinary Incontinence</keyword>
	<keyword>Urinary Stress Incontinence</keyword>
	<keyword>Lower Urinary Tract Symptoms</keyword>
	<keyword>Urinary Bladder</keyword>
	<keyword>Urinary Tract Diseases</keyword>
	<keyword>Bladder</keyword>
	<keyword>Urinary Leak</keyword>
	<keyword>Urine Leak</keyword>
	<keyword>Bladder Leak</keyword>
	<keyword>Urethra</keyword>
	<keyword>Urethral Sphincter</keyword>
</DOC>